In a webinar I gave last week, “Over Outlook? Simplify your PV mailbox with NLP technology,” I introduced a scale that I call “Case Processing Evolution.” These five steps cover what we’ve found repeatedly at pharmaceutical companies—where they’ve come from and where they’re going on the road to automation.
In case you missed it, here are the five steps to automation.
When companies are just starting out, they may find themselves in the “Any Means Necessary” Phase. You may be in this phase if:
Your company has no standardized way to accept reports—you’re just trying to manage them wherever they come in.
If this sounds like you, then it’s time to take a step back and start working toward the next phase.
It’s not perfect, but it’s a lot better! These companies may not be using the newest technology, but they’re finding ways to make their process more effective:
This is where it starts getting good. Not only is your AE Intake Process fully digital, its also fully validated!
In the evolution of technology, AI (Artificial Intelligence) pops up towards the end of our timeline—but that doesn’t mean that it can’t support your processes in other stages of evolution. A well thought-out Natural Language Processing application can help you triage new cases for language, seriousness, and completeness without painful infrastructural changes.
In an ideal world, anything that could be done by a machine would be—from intake, translation through verification—the software would handle processing and only require human intervention when they’re needed most.
As we all know, today’s technology hasn’t gotten there – and neither have our regulations. That won’t stop us from dreaming though!